Dr. Yong-Xiao Wang is a Full Professor in the Department of Molecular and Cellular Physiology at Albany Medical College, Albany, New York, USA. He received his M.D. at the Wannan Medical College (China), Ph.D. at the Fourth Military Medical University (China), and postdoctoral training at the Technical University of Munich (Germany) as well as the University of Pennsylvania (USA). Dr. Wang’s primary research interests have focused on basic, translational, and drug discovery research concerning cardiac arrhythmias and hypertrophy, pulmonary hypertension, asthma, and diabetes for over 30 years. In particular, he has had extensive research experience in the studies of the molecular geneses, regulatory mechanisms, network pathways, physiological functions, and the critical roles of calcium, redox, inflammatory, and other signaling in the aforementioned illnesses. Dr. Wang has been the corresponding author, first author, and key contributor in numerous publications in highly peer-reviewed journals including Nat Commun, Antioxid Redox Signal, Proc Natl Acad Sci USA, Free Radic Biol Med, Cell Calcium, J Gen Physiol, J Biol Chem, FASEB J, Nature, Circ Res, and more. He has been the editor of several academic books in the field including a recent one entitled “Pulmonary Vasculature Redox Signaling in Health and Disease” that was published by Springer International Publishing AG in 2017. Dr. Wang has been the principal investigator on multiple research grants and awards from the National Institutes of Health, American Heart Association, American Diabetes Association, and other agencies. He has collaborated with numerous well-known scientists, served on various grant review panels, been the Editor-In-Chief and Editorial Board Member for several scientific journals, and trained a number of scholars, some of whom have become well-known independent investigators in the field.

• 1. Potential role of mast cells in regulating corticosteroid insensitivity in severe asthma.- 2. Galectin-3 Promotes ROS, Inflammation and Vascular Fibrosis in Pulmonary Arterial Hypertension.- 3. Anti-Inflammatory Effects of Statins in Lung Vascular Pathology: From Basic Science to Clinical Trials.- 4. Evolving Schema for Employing Network Biology Approaches to Understand Pulmonary Hypertension.- 5. Pulmonary Inflammation and KRAS Mutation in Lung Cancer.- 6. microRNA Targets for Asthma Therapy.- 7. Roles of genetic predisposition in the sex-bias of pulmonary pathophysiology, as a function of estrogens.- 8. Hypercapnic respiratory failure-driven skeletal muscle dysfunction: It is time for animal mod-els-based mechanistic research.- 9. Role of airway smooth muscle in inflammation related to asthma and COPD.- 10. Systemic Sclerosis and Pulmonary Disease.- 11. Innate Lymphoid Cells in airway inflammation.- 12. Sjogren’s Syndrome and pulmonary disease.- 13. Redox Regulation, Oxidative Stress and Inflammation in Group 3 Pulmonary Hypertension.- 14. Sex-Steroid Signaling in Lung Diseases and Inflammation.- 15. Cytokines, Chemokines and Inflammation in Pulmonary Arterial Hypertension.- 16. Interactive roles of CaMKII/Ryanodine Receptor Signaling and Inflammation in Lung Diseases.- 17. Reciprocal Correlations of Inflammatory and Calcium Signaling in Asthma Pathogenesis.- 18. Crosstalk between Lung and Extrapulmonary Organs in Infection and Inflammation.- 19. Inflammation in Pulmonary Arterial Hypertension.- 20. Lysophospholids in Lung Inflammatory Diseases.

Dr. Yong-Xiao Wang is a Full Professor in the Department of Molecular and Cellular Physiology at Albany Medical College, Albany, New York, USA. He received his M.D. at the Wannan Medical College (China), Ph.D. at the Fourth Military Medical University (China), and postdoctoral training at the Technical University of Munich (Germany) as well as the University of Pennsylvania (USA). Dr. Wang’s primary research interests have focused on basic, translational, and drug discovery research concerning cardiac arrhythmias and hypertrophy, pulmonary hypertension, asthma, and diabetes for over 30 years. In particular, he has had extensive research experience in the studies of the molecular geneses, regulatory mechanisms, network pathways, physiological functions, and the critical roles of calcium, redox, inflammatory, and other signaling in the aforementioned illnesses. Dr. Wang has been the corresponding author, first author, and key contributor in numerous publications in highly peer-reviewed journals including Nat Commun, Antioxid Redox Signal, Proc Natl Acad Sci USA, Free Radic Biol Med, Cell Calcium, J Gen Physiol, J Biol Chem, FASEB J, Nature, Circ Res, and more. He has been the editor of several academic books in the field including a recent one entitled “Pulmonary Vasculature Redox Signaling in Health and Disease” that was published by Springer International Publishing AG in 2017. Dr. Wang has been the principal investigator on multiple research grants and awards from the National Institutes of Health, American Heart Association, American Diabetes Association, and other agencies. He has collaborated with numerous well-known scientists, served on various grant review panels, been the Editor-In-Chief and Editorial Board Member for several scientific journals, and trained a number of scholars, some of whom have become well-known independent investigators in the field.

• 1. Potential role of mast cells in regulating corticosteroid insensitivity in severe asthma.- 2. Galectin-3 Promotes ROS, Inflammation and Vascular Fibrosis in Pulmonary Arterial Hypertension.- 3. Anti-Inflammatory Effects of Statins in Lung Vascular Pathology: From Basic Science to Clinical Trials.- 4. Evolving Schema for Employing Network Biology Approaches to Understand Pulmonary Hypertension.- 5. Pulmonary Inflammation and KRAS Mutation in Lung Cancer.- 6. microRNA Targets for Asthma Therapy.- 7. Roles of genetic predisposition in the sex-bias of pulmonary pathophysiology, as a function of estrogens.- 8. Hypercapnic respiratory failure-driven skeletal muscle dysfunction: It is time for animal mod-els-based mechanistic research.- 9. Role of airway smooth muscle in inflammation related to asthma and COPD.- 10. Systemic Sclerosis and Pulmonary Disease.- 11. Innate Lymphoid Cells in airway inflammation.- 12. Sjogren’s Syndrome and pulmonary disease.- 13. Redox Regulation, Oxidative Stress and Inflammation in Group 3 Pulmonary Hypertension.- 14. Sex-Steroid Signaling in Lung Diseases and Inflammation.- 15. Cytokines, Chemokines and Inflammation in Pulmonary Arterial Hypertension.- 16. Interactive roles of CaMKII/Ryanodine Receptor Signaling and Inflammation in Lung Diseases.- 17. Reciprocal Correlations of Inflammatory and Calcium Signaling in Asthma Pathogenesis.- 18. Crosstalk between Lung and Extrapulmonary Organs in Infection and Inflammation.- 19. Inflammation in Pulmonary Arterial Hypertension.- 20. Lysophospholids in Lung Inflammatory Diseases.

Dr. Yong-Xiao Wang is a Full Professor in the Department of Molecular and Cellular Physiology at Albany Medical College, Albany, New York, USA. He received his M.D. at the Wannan Medical College (China), Ph.D. at the Fourth Military Medical University (China), and postdoctoral training at the Technical University of Munich (Germany) as well as the University of Pennsylvania (USA). Dr. Wang’s primary research interests have focused on basic, translational, and drug discovery research concerning cardiac arrhythmias and hypertrophy, pulmonary hypertension, asthma, and diabetes for over 30 years. In particular, he has had extensive research experience in the studies of the molecular geneses, regulatory mechanisms, network pathways, physiological functions, and the critical roles of calcium, redox, inflammatory, and other signaling in the aforementioned illnesses. Dr. Wang has been the corresponding author, first author, and key contributor in numerous publications in highly peer-reviewed journals including Nat Commun, Antioxid Redox Signal, Proc Natl Acad Sci USA, Free Radic Biol Med, Cell Calcium, J Gen Physiol, J Biol Chem, FASEB J, Nature, Circ Res, and more. He has been the editor of several academic books in the field including a recent one entitled “Pulmonary Vasculature Redox Signaling in Health and Disease” that was published by Springer International Publishing AG in 2017. Dr. Wang has been the principal investigator on multiple research grants and awards from the National Institutes of Health, American Heart Association, American Diabetes Association, and other agencies. He has collaborated with numerous well-known scientists, served on various grant review panels, been the Editor-In-Chief and Editorial Board Member for several scientific journals, and trained a number of scholars, some of whom have become well-known independent investigators in the field.

• 1. Potential role of mast cells in regulating corticosteroid insensitivity in severe asthma.- 2. Galectin-3 Promotes ROS, Inflammation and Vascular Fibrosis in Pulmonary Arterial Hypertension.- 3. Anti-Inflammatory Effects of Statins in Lung Vascular Pathology: From Basic Science to Clinical Trials.- 4. Evolving Schema for Employing Network Biology Approaches to Understand Pulmonary Hypertension.- 5. Pulmonary Inflammation and KRAS Mutation in Lung Cancer.- 6. microRNA Targets for Asthma Therapy.- 7. Roles of genetic predisposition in the sex-bias of pulmonary pathophysiology, as a function of estrogens.- 8. Hypercapnic respiratory failure-driven skeletal muscle dysfunction: It is time for animal mod-els-based mechanistic research.- 9. Role of airway smooth muscle in inflammation related to asthma and COPD.- 10. Systemic Sclerosis and Pulmonary Disease.- 11. Innate Lymphoid Cells in airway inflammation.- 12. Sjogren’s Syndrome and pulmonary disease.- 13. Redox Regulation, Oxidative Stress and Inflammation in Group 3 Pulmonary Hypertension.- 14. Sex-Steroid Signaling in Lung Diseases and Inflammation.- 15. Cytokines, Chemokines and Inflammation in Pulmonary Arterial Hypertension.- 16. Interactive roles of CaMKII/Ryanodine Receptor Signaling and Inflammation in Lung Diseases.- 17. Reciprocal Correlations of Inflammatory and Calcium Signaling in Asthma Pathogenesis.- 18. Crosstalk between Lung and Extrapulmonary Organs in Infection and Inflammation.- 19. Inflammation in Pulmonary Arterial Hypertension.- 20. Lysophospholids in Lung Inflammatory Diseases.